Abstract
In our large observational cohort, use of tenofovir disoproxil fumarate (n = 344) was associated with a greater decline in renal function than was use of alternative nucleoside analogues (n = 314). Other associations included a lower CD4 cell count, decreased renal function at baseline, and diabetes. The declines were modest and did not lead to greater rates of discontinuation of therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 1194-1198 |
Number of pages | 5 |
Journal | Clinical Infectious Diseases |
Volume | 40 |
Issue number | 8 |
DOIs | |
State | Published - Apr 15 2005 |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases